Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification.
Ingrid J Guldvik,
Verena Zuber,
Peder R Braadland,
Helene H Grytli,
Håkon Ramberg,
Wolfgang Lilleby,
Bernd Thiede,
Manuela Zucknick,
Fahri Saatcioglu,
Randi Gislefoss,
Rune Kvåle,
Anne George,
Henrik Grönberg,
Fredrik Wiklund,
David E Neal,
Vincent J Gnanapragasam,
Kristin A Taskén,
Ian G Mills
Oct 13, 2021
BACKGROUND: More accurate risk assessments are needed to improve prostate cancer management. OBJECTIVE: To identify blood-based protein biomarkers that provided prognostic information for risk stratification. DESIGN SETTING AND...